Rhumbline Advisers »

Entrada Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $418k 30k 14.17
2023-12-31 $430k 29k 15.09
2023-09-30 $418k 26k 15.80
2023-06-30 $367k 24k 15.14